Cargando…

Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis

Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xutengyue, Wang, Jiayi, Jiang, Lanxin, Jiang, Yuchen, Xu, Juan, Feng, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578795/
https://www.ncbi.nlm.nih.gov/pubmed/36268282
http://dx.doi.org/10.1155/2022/2208176
_version_ 1784812037335941120
author Tian, Xutengyue
Wang, Jiayi
Jiang, Lanxin
Jiang, Yuchen
Xu, Juan
Feng, Xiaodong
author_facet Tian, Xutengyue
Wang, Jiayi
Jiang, Lanxin
Jiang, Yuchen
Xu, Juan
Feng, Xiaodong
author_sort Tian, Xutengyue
collection PubMed
description Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional links between chemokine/GPCR signaling-mediated EMT and metastasis remain unclear. Herein, we summarized the mechanisms of chemokine/GPCR signaling-mediated EMT with an insight into facilitating metastasis and clarified the role of chemokine in the local invasion, intravasation, circulation, extravasation, and colonization, respectively. Moreover, several potential pathways that might contribute to EMT based on the latest studies on GPCR signaling were proposed, including signaling mediated by G protein, β-arrestin, intracellular, dimerization activation, and transactivation. However, there is still limited evidence to support the EMT programme functional contribution to metastasis, which keeps a key question still open whether we should target EMT programme of cancer cells. Answers to that question might help develop an anticancer strategy or guide new directions for anticancer metastasis therapy.
format Online
Article
Text
id pubmed-9578795
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95787952022-10-19 Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis Tian, Xutengyue Wang, Jiayi Jiang, Lanxin Jiang, Yuchen Xu, Juan Feng, Xiaodong J Oncol Review Article Metastasis, the chief cause of cancer-related deaths, is associated with epithelial-mesenchymal transition (EMT). In the tumor microenvironment, EMT can be triggered by chemokine/G-protein-coupled receptor (GPCR) signaling, which is closely associated with tumor progression. However, the functional links between chemokine/GPCR signaling-mediated EMT and metastasis remain unclear. Herein, we summarized the mechanisms of chemokine/GPCR signaling-mediated EMT with an insight into facilitating metastasis and clarified the role of chemokine in the local invasion, intravasation, circulation, extravasation, and colonization, respectively. Moreover, several potential pathways that might contribute to EMT based on the latest studies on GPCR signaling were proposed, including signaling mediated by G protein, β-arrestin, intracellular, dimerization activation, and transactivation. However, there is still limited evidence to support the EMT programme functional contribution to metastasis, which keeps a key question still open whether we should target EMT programme of cancer cells. Answers to that question might help develop an anticancer strategy or guide new directions for anticancer metastasis therapy. Hindawi 2022-10-11 /pmc/articles/PMC9578795/ /pubmed/36268282 http://dx.doi.org/10.1155/2022/2208176 Text en Copyright © 2022 Xutengyue Tian et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Tian, Xutengyue
Wang, Jiayi
Jiang, Lanxin
Jiang, Yuchen
Xu, Juan
Feng, Xiaodong
Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title_full Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title_fullStr Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title_full_unstemmed Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title_short Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
title_sort chemokine/gpcr signaling-mediated emt in cancer metastasis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578795/
https://www.ncbi.nlm.nih.gov/pubmed/36268282
http://dx.doi.org/10.1155/2022/2208176
work_keys_str_mv AT tianxutengyue chemokinegpcrsignalingmediatedemtincancermetastasis
AT wangjiayi chemokinegpcrsignalingmediatedemtincancermetastasis
AT jianglanxin chemokinegpcrsignalingmediatedemtincancermetastasis
AT jiangyuchen chemokinegpcrsignalingmediatedemtincancermetastasis
AT xujuan chemokinegpcrsignalingmediatedemtincancermetastasis
AT fengxiaodong chemokinegpcrsignalingmediatedemtincancermetastasis